NASDAQ: LGND       Ligand Pharm
Last Price Today's Change   Day's Range   Trading Volume
161.87   -5.07 (3.04%)  161.50 - 169.14  303,376


Avg Volume (4 weeks):351,794
4 Weeks Range:150.59 - 184.79
4 Weeks Price Volatility (%):
52 Weeks Range:102.56 - 184.79
52 Weeks Price Volatility (%):
Average Price Target: 94.00
Price Target Upside/Downside: -67.87


No recent Headlines for this stock.

Business Background

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others.

  Be the first to like this.


1907  5559  510  585 

Top 10 Active Counters
 SPY 263.67-6.76 
 BAC 30.55-1.32 
 EEM 47.86-1.65 
 WFT 2.39-0.07 
 TVIX 9.52+1.90 
 XLF 27.66-1.06 
 NVCN 0.114+0.008 
 UVXY 18.68+3.09 
 FB 164.89-4.50 
 GE 13.35-0.53 
Partners & Brokers